IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 2081 - 2090 of 4290 for "Omar S. Bassiouny" with applied filters

News & Analysis

Nigeria: The Securities and Exchange Commission (SEC) Statement on the Classification and Treatment of Digital Assets

18 December 2020 by Minerva Legal

The Securities and Exchange Commission (“SEC” or “the Commission”) issued an official statement (“the Statement”) on 14 September 2020 on the classification and treatment of Digital Assets (crypto assets such as crypto currencies and tokens).
News & Analysis

JPM is happy to support BASF in Closure on sale of Construction Chemicals business in Serbia

11 December 2020 by JPM Janković Popović Mitić

In 2019, BASF and an affiliate of Lone Star, a global private equity firm, signed an agreement for the acquisition of BASF’s Construction Chemicals business worldwide.
News & Analysis

Yanos Gramatidis is the chairperson of Session VI & the following “In Conversation” of the 2nd Southeast Europe & East Med – Digital Conference.

11 December 2020 by Bahas Gramatidis & Partners

Yanos Gramatidis, Partner of Bahas, Gramatidis & Partners, in his capacity as the Honorary President of the American-Hellenic Chamber of Commerce, is the chairperson of Session VI “US-Greece Investment Ties: Magnitude and Scope” & the following “In Conversation” of the 2nd Southeast Europe & East Med – Digital Conference, organized by the Delphi Economic Forum in association with the Hellenic Association Leadership Council & Hellas Journal.
News & Analysis

Highway to the debt zone

08 December 2020 by GSK

Following a decade of unprecedented growth worldwide, debt capital markets continue to boom. Innovative investment vehicles emerge, structured finance and securitisation capabilities expand and new routes for funding the real economy develop. Driven by a regulatory wave and historic low interests, the industry has gone through transformative changes over the last few decades and is now playing a key role in the Capital Markets Union, the European Commission’s action plan for a more inclusive and resilient economy.
News & Analysis

Olaniwun Ajayi – NIGERIA LAW FIRM OF THE YEAR

07 December 2020 by IFLR Correspondent

Olaniwun Ajayi won IFLR’s inaugural Nigeria Law Firm of the Year award for its work on many of the market’s most innovative cross-border transactions of 2019-2020.
News & Analysis

Helmy, Hamza & Partners, Baker McKenzie Cairo advises National Service Projects Organization on its strategic collaboration with Grifols

02 December 2020 by Helmy Hamza & Partners

Cairo, Egypt, December 2, 2020 - Helmy, Hamza & Partners, Baker McKenzie Cairo office, has represented the National Service Projects Organization (NSPO), on a strategic joint venture with Grifols, one of the world's leading producers of plasma-derived medicines. The collaboration is a significant opportunity to develop the Egyptian plasma-derivatives market and promote its self-sufficiency.
News & Analysis

Helmy, Hamza & Partners, Baker McKenzie Cairo advises on syndicated financing to a subsidiary of Orascom Development Holding

30 November 2020 by Helmy Hamza & Partners

Cairo, Egypt, November 30, 2020 - Helmy, Hamza & Partners, Baker McKenzie Cairo office, represented four syndicated lenders in relation to a multicurrency syndicated facilities agreement with Orascom Development Egypt (ODE), a subsidiary of Orascom Development Holding
News & Analysis

Luxembourg: Arendt acquires digitalisation and robotisation specialist Mobilu

25 November 2020 by Arendt & Medernach

With a view to accelerating its digitalisation strategy, Arendt recently acquired a majority shareholding in Mobilu, a Luxembourg company specialising in operational processes, digitalisation and robotised automation.
News & Analysis

Media: 'Benelux Law Firm AKD Appoints 6 New Partners, Associates in Luxembourg'

19 November 2020 by AKD

AKD Benelux lawyers has announced the appointment of six new partners and associates in Luxembourg.
News & Analysis

Homburger advised Vifor

16 November 2020 by Homburger

On November 9, 2020, Vifor Pharma and Angion Biomedica Corp. announced the signing of a licensing agreement for the commercialization of Angion’s ANG-3777
Load more